KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Acquisitions (2017 - 2023)

Exact Sciences (EXAS) has disclosed Acquisitions for 6 consecutive years, with $2.4 million as the latest value for Q4 2023.

  • Quarterly Acquisitions fell 84.3% to $2.4 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $67.8 million through Dec 2024, up 2.06% year-over-year, with the annual reading at $52.4 million for FY2023, 256.89% up from the prior year.
  • Acquisitions for Q4 2023 was $2.4 million at Exact Sciences, down from $50.0 million in the prior quarter.
  • The five-year high for Acquisitions was $973.9 million in Q4 2019, with the low at -$1.5 million in Q2 2020.
  • Average Acquisitions over 5 years is $128.9 million, with a median of $11.8 million recorded in 2022.
  • The sharpest move saw Acquisitions skyrocketed 4776.65% in 2021, then plummeted 99.05% in 2022.
  • Over 5 years, Acquisitions stood at $973.9 million in 2019, then tumbled by 100.0% to $4000.0 in 2020, then skyrocketed by 2104425.0% to $84.2 million in 2021, then tumbled by 81.74% to $15.4 million in 2022, then tumbled by 84.3% to $2.4 million in 2023.
  • According to Business Quant data, Acquisitions over the past three periods came in at $2.4 million, $50.0 million, and $15.4 million for Q4 2023, Q3 2023, and Q4 2022 respectively.